RVC Medical IT has been acquired by NEXUS AG
Main Capital Partners B.V. has sold RVC Medical IT B.V. to NEXUS AG.
RVC Medical IT is an innovative independent software vendor offering a comprehensive healthcare enterprise imaging software suite. RVC’s product range comprises specialized front-end client software for diagnostic workstations of radiology and all medical specialties outside radiology, complemented with a vendor neutral archive (VNA), RVC clinical repository, which can store all types of images (DICOM and Non-DICOM), documents, data and signals. Notable customers include Isala, UMC Utrecht, Tergooi, Kliniken des Landeskreises Lörrach and UZ Gent. The company is headquartered in Amersfoort, the Netherlands and employs more than 70 people. It has a market share of around 53% and a customer base of 41 hospitals.
Headquartered in Germany and with over 1,300 employees, NEXUS is a leading European healthcare software company and provider of hospital and diagnostic information systems.
Main Capital is a strategic investor with an exclusive focus on the software sector in the Benelux, DACH and Nordics regions. The firm has a long-term strategy of forming successful partnerships with management teams, with the aim of building larger software groups together. Main Capital has over US$1 billion in assets under management for investments in mature and growing software companies.
Oaklins’ team in the Netherlands advised the shareholders of RVC Medical IT.
Talk to the deal team
Frederik van der Schoot
Managing PartnerAmsterdam, Netherlands
Martijn de Win
Associate DirectorAmsterdam, Netherlands
VHZ Group has been acquired by Gilde Equity Management and VHZ Group’s management
VHZ Group, the market leader in the Dutch B2B uPVC windows and doors market, has been acquired by Gilde Equity Management (GEM) together with the company’s management. With the acquisition, VHZ Group and GEM will be able to further expand on the company’s strategy and vision.Learn more
ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners
Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised US$28 million (€24 million) in a Series C funding round led by New York-based global venture capital and private equity firm Insight Partners to further develop its technology and accelerate commercial growth of the company’s Transpara AI breast care software.Learn more
esignatur has been acquired by Scrive
esignatur has been acquired by Scrive, a portfolio company of Vitruvian Partners. esignatur and Scrive both specialize in digital signing solutions and complement each other with strong geographical and sector reach.Learn more